Chronic lymphocytic leukaemia (CLL) is a heterogeneous disease with some patients having progressive disease requiring therapy soon after diagnosis whereas others may have indolent disease that does not require immediate treatment (Zhang & Kipps 1981). This section will cover aspects of CLL that indicate the potential clinical course and outcomes for patients with the disease and to help the clinician in making informed treatment choices.